Bioretec, Ltds

Bioretec Ltd's financial statements bulletin 2024: Foundation for future growth in 2024 - CE mark received in January 2025

07.08.2025 - 18:05:13

Bioretec Finland

 

Johanna Salko
CFO
+358 40 754 8172
johanna.salko@bioretec.com  

Certified Adviser

Nordic Certified Adviser AB, +46 70 551 67 29 

Information about Bioretec

Bioretec is a globally operating Finnish medical device company that continues to pioneer the application of absorbable orthopedic implants. The company has built unique competencies in the?biological interface?of active implants?to enhance bone growth and accelerate fracture healing after orthopedic surgery. The products developed and manufactured by Bioretec are used worldwide in approximately 40 countries.?

Bioretec is?developing?the new RemeOs™?product line?based on a magnesium alloy and hybrid composite, introducing a new generation of strong absorbable materials for enhanced surgical outcomes. The RemeOs™ implants are absorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The combination has the potential to make titanium implants redundant and help clinics reach their Value-Based Healthcare targets while focusing on?value for patients through efficient healthcare. The first RemeOs™ product market authorization has been received in the U.S. in March 2023, and in Europe, the CE mark approval was received in January 2025. Bioretec is positioning itself to enter the addressable over USD 9 billion global orthopedic trauma and spine market and to become a game changer in surgical bone fracture treatment.

Better Healing – Better Life. ?www.bioretec.com

Appendix

Bioretec Ltd's financial statements bulletin January–December 2024 (pdf)

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/bioretec/r/bioretec-ltd-s-financial-statements-bulletin-2024--foundation-for-future-growth-in-2024---ce-mark-re,c4105638

The following files are available for download:

https://mb.cision.com/Main/20509/4105638/3265696.pdf

Bioretec Financial Statements Bulletin 0101-31122024

 

 

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/bioretec-ltds-financial-statements-bulletin-2024-foundation-for-future-growth-in-2024--ce-mark-received-in-january-2025-302376896.html

@ prnewswire.co.uk